527 related articles for article (PubMed ID: 21120523)
1. Promoter CpG island hypermethylation during breast cancer progression.
Park SY; Kwon HJ; Lee HE; Ryu HS; Kim SW; Kim JH; Kim IA; Jung N; Cho NY; Kang GH
Virchows Arch; 2011 Jan; 458(1):73-84. PubMed ID: 21120523
[TBL] [Abstract][Full Text] [Related]
2. [Detection and clinical significance of Notch1 methylation in breast cancer and intraductal proliferative breast lesions].
Zhang N; Sun ZZ; Li F; Cao YW; Zhao CX; Liang WH; Sun HP; Li HA; Fu XG
Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):324-9. PubMed ID: 21756827
[TBL] [Abstract][Full Text] [Related]
3. Distinct patterns of promoter CpG island methylation of breast cancer subtypes are associated with stem cell phenotypes.
Park SY; Kwon HJ; Choi Y; Lee HE; Kim SW; Kim JH; Kim IA; Jung N; Cho NY; Kang GH
Mod Pathol; 2012 Feb; 25(2):185-96. PubMed ID: 22037257
[TBL] [Abstract][Full Text] [Related]
4. Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer.
Moelans CB; Verschuur-Maes AH; van Diest PJ
J Pathol; 2011 Oct; 225(2):222-31. PubMed ID: 21710692
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation profile during multistage progression of pulmonary adenocarcinomas.
Chung JH; Lee HJ; Kim BH; Cho NY; Kang GH
Virchows Arch; 2011 Aug; 459(2):201-11. PubMed ID: 21494759
[TBL] [Abstract][Full Text] [Related]
6. Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer.
Muggerud AA; Rønneberg JA; Wärnberg F; Botling J; Busato F; Jovanovic J; Solvang H; Bukholm I; Børresen-Dale AL; Kristensen VN; Sørlie T; Tost J
Breast Cancer Res; 2010; 12(1):R3. PubMed ID: 20056007
[TBL] [Abstract][Full Text] [Related]
7. RUNX3 inactivation by frequent promoter hypermethylation and protein mislocalization constitute an early event in breast cancer progression.
Subramaniam MM; Chan JY; Soong R; Ito K; Ito Y; Yeoh KG; Salto-Tellez M; Putti TC
Breast Cancer Res Treat; 2009 Jan; 113(1):113-21. PubMed ID: 18256927
[TBL] [Abstract][Full Text] [Related]
8. Role of deregulated microRNAs in breast cancer progression using FFPE tissue.
Chen L; Li Y; Fu Y; Peng J; Mo MH; Stamatakos M; Teal CB; Brem RF; Stojadinovic A; Grinkemeyer M; McCaffrey TA; Man YG; Fu SW
PLoS One; 2013; 8(1):e54213. PubMed ID: 23372687
[TBL] [Abstract][Full Text] [Related]
9. Methylation in the p53 promoter is a supplementary route to breast carcinogenesis: correlation between CpG methylation in the p53 promoter and the mutation of the p53 gene in the progression from ductal carcinoma in situ to invasive ductal carcinoma.
Kang JH; Kim SJ; Noh DY; Park IA; Choe KJ; Yoo OJ; Kang HS
Lab Invest; 2001 Apr; 81(4):573-9. PubMed ID: 11304577
[TBL] [Abstract][Full Text] [Related]
10. CpG island methylation profile of estrogen receptor alpha in Iranian females with triple negative or non-triple negative breast cancer: new marker of poor prognosis.
Ramezani F; Salami S; Omrani MD; Maleki D
Asian Pac J Cancer Prev; 2012; 13(2):451-7. PubMed ID: 22524805
[TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation in ductal carcinoma in situ of the male breast.
Vermeulen MA; van Deurzen CHM; Doebar SC; de Leng WWJ; Martens JWM; van Diest PJ; Moelans CB
Endocr Relat Cancer; 2019 Jun; 26(6):575-584. PubMed ID: 30921768
[TBL] [Abstract][Full Text] [Related]
12. A study of the role of Notch1 and JAG1 gene methylation in development of breast cancer.
Sun H; Li K; Shen S
Med Oncol; 2016 Apr; 33(4):35. PubMed ID: 26971121
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic progression of columnar cell lesions of the breast to invasive breast cancer.
Verschuur-Maes AH; de Bruin PC; van Diest PJ
Breast Cancer Res Treat; 2012 Dec; 136(3):705-15. PubMed ID: 23104224
[TBL] [Abstract][Full Text] [Related]
14. Evidence of chromosomal alterations in pure usual ductal hyperplasia as a breast carcinoma precursor.
Xu S; Wei B; Zhang H; Qing M; Bu H
Oncol Rep; 2008 Jun; 19(6):1469-75. PubMed ID: 18497952
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation profiles of gastric carcinoma characterized by quantitative DNA methylation analysis.
Kang GH; Lee S; Cho NY; Gandamihardja T; Long TI; Weisenberger DJ; Campan M; Laird PW
Lab Invest; 2008 Feb; 88(2):161-70. PubMed ID: 18158559
[TBL] [Abstract][Full Text] [Related]
16. [Promoter methylation and mRNA expression of WT1 gene in MCF10 breast cancer model].
Yang JL; Klinkebiel D; Boland MJ; Tang L; Christman JK
Zhonghua Bing Li Xue Za Zhi; 2007 Apr; 36(4):253-8. PubMed ID: 17706117
[TBL] [Abstract][Full Text] [Related]
17. Lack of RUNX3 inactivation in columnar cell lesions of breast.
Subramaniam MM; Chan JY; Omar MF; Ito K; Ito Y; Yeoh KG; Salto-Tellez M; Putti TC
Histopathology; 2010 Oct; 57(4):555-63. PubMed ID: 20955380
[TBL] [Abstract][Full Text] [Related]
18. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].
Yang M; Xu SP; Ao QL
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):257-61. PubMed ID: 23928534
[TBL] [Abstract][Full Text] [Related]
19. Methylation profiling of ductal carcinoma in situ and its relationship to histopathological features.
Pang JM; Deb S; Takano EA; Byrne DJ; Jene N; Boulghourjian A; Holliday A; Millar E; Lee CS; O'Toole SA; Dobrovic A; Fox SB
Breast Cancer Res; 2014 Oct; 16(5):423. PubMed ID: 25331261
[TBL] [Abstract][Full Text] [Related]
20. Alu and LINE-1 hypomethylation is associated with HER2 enriched subtype of breast cancer.
Park SY; Seo AN; Jung HY; Gwak JM; Jung N; Cho NY; Kang GH
PLoS One; 2014; 9(6):e100429. PubMed ID: 24971511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
